SecBot SecBot
SECBOTREPLAY Home › Report › KURA

KURA · Kura Oncology CEO Troy Wilson purchased $1.11M of stock on the open…

Kura Oncology, Inc. · CLUSTER filed Aug 21, 2026 at 16:30 ET

At the news

BULLISHIMPACT 6/10

CLUSTER filed Aug 21, 2026 at 16:30 ET

Kura Oncology CEO Troy Wilson purchased $1.11M of stock on the open market at $11.12/share, while Chief Legal Officer Teresa Brophy sold $398K at $12.63. The CEO's large open-market buy is a strong bullish signal, especially given the company's $1.0B market cap, while the CLO's sale is routine in size and likely liquidity-driven. The net direction is mixed by count but heavily skewed to buying by dollar value and insider seniority.

  • CEO Troy Wilson purchased 100,000 shares for $1.11M at $11.12 on 2026-08-17
  • CLO Teresa Brophy sold 31,487 shares for $398K at $12.63 on 2026-08-19
  • CEO buy represents ~0.11% of KURA's $1.0B market cap
  • CLO sale represents ~0.04% of market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access